Craig Greathouse
Chief Administrative Officer at MVB FINANCIAL CORP.
Net worth: 403 706 $ as of 30/05/2024
Craig Greathouse active positions
Companies | Position | Start | End |
---|---|---|---|
MVB FINANCIAL CORP. | Chief Administrative Officer | 26/01/2022 | - |
Human Resources Officer | 09/05/2018 | 26/01/2022 |
Career history of Craig Greathouse
Former positions of Craig Greathouse
Companies | Position | Start | End |
---|---|---|---|
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Human Resources Officer | 31/12/2009 | 31/12/2017 |
United Way of Monongalia & Preston Counties | Director/Board Member | - | - |
Corporate Officer/Principal | - | - |
Training of Craig Greathouse
West Virginia University | Undergraduate Degree |
University of South Carolina | Graduate Degree |
Statistics
International
United States | 6 |
Operational
Human Resources Officer | 2 |
Chief Administrative Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MVB FINANCIAL CORP. | Finance |
Private companies | 2 |
---|---|
United Way of Monongalia & Preston Counties | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
- Stock Market
- Insiders
- Craig Greathouse
- Experience